Cargando…
Metabolic reprogramming of glycolysis and glutamine metabolism are key events in myofibroblast transition in systemic sclerosis pathogenesis
Systemic Sclerosis (SSc) is a rare fibrotic autoimmune disorder for which no curative treatments currently exist. Metabolic remodelling has recently been implicated in other autoimmune diseases; however, its potential role in SSc has received little attention. Here, we aimed to determine whether cha...
Autores principales: | Henderson, John, Duffy, Laura, Stratton, Richard, Ford, Dianne, O’Reilly, Steven |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754020/ https://www.ncbi.nlm.nih.gov/pubmed/33140521 http://dx.doi.org/10.1111/jcmm.16013 |
Ejemplares similares
-
Bone Morphogenetic Protein Antagonist Gremlin-1 Increases Myofibroblast Transition in Dermal Fibroblasts: Implications for Systemic Sclerosis
por: Duffy, Laura, et al.
Publicado: (2021) -
A Metabolic Reprogramming of Glycolysis and Glutamine Metabolism Is a Requisite for Renal Fibrogenesis—Why and How?
por: Hewitson, Timothy D., et al.
Publicado: (2021) -
Key Roles of Glutamine Pathways in Reprogramming the Cancer Metabolism
por: Michalak, Krzysztof Piotr, et al.
Publicado: (2015) -
Glutamine metabolic reprogramming in hepatocellular carcinoma
por: Ye, Yanyan, et al.
Publicado: (2023) -
SARS-CoV-2 and Glutamine: SARS-CoV-2 Triggered Pathogenesis via Metabolic Reprograming of Glutamine in Host Cells
por: Bharadwaj, Shiv, et al.
Publicado: (2021)